Humoral immune response to influenza vaccine in natalizumab-treated MS patients

OBJECTIVES: Natalizumab is a drug with documented efficacy in relapsing?remitting multiple sclerosis (RRMS). The mechanism of action of natalizumab has immunosuppressive properties and it is not ye ...